Medical balancing devices such as exoskeletons and orthoses require CE marking for European markets, FDA approval for the United States, and ISO 13485 certification for quality management. The specific certifications depend on device classification, intended use, and target markets. Most balancing devices fall under Class I or Class II medical device categories, each with distinct regulatory requirements and approval processes.
What certifications do medical balancing devices actually need?
Medical balancing devices require different certifications based on their intended use and target markets. CE marking is mandatory for all medical devices sold in Europe, while FDA approval is required for the US market. ISO 13485 certification demonstrates quality management compliance across most global markets.
For orthoses and exoskeletons, the primary certifications include:
- CE marking – Required for European Economic Area sales
- FDA 510(k) clearance or De Novo pathway – Needed for US market access
- ISO 13485 – Quality management system standard
- ISO 14971 – Risk management for medical devices
- IEC 62304 – Software lifecycle processes (for devices with software)
The specific certifications depend on your device classification. Simple orthoses might only need Class I registration, while powered exoskeletons typically require more comprehensive Class II approvals. You will also need to consider additional standards such as biocompatibility testing (ISO 10993) if your device contacts skin for extended periods.
How does the certification process work for medical balancing devices?
The certification process follows a structured pathway from initial design through regulatory approval. It begins with device classification, continues through clinical testing and documentation, involves notified body review for higher-risk devices, and concludes with market authorisation. The timeline varies from months for Class I devices to several years for Class III devices.
The certification journey typically includes these phases:
- Classification determination – Establish the risk class and applicable regulations
- Quality system implementation – Set up ISO 13485-compliant processes
- Technical documentation preparation – Create design files, risk analyses, and clinical data
- Testing and validation – Conduct safety, performance, and biocompatibility tests
- Notified body review – Submit technical files for assessment (Class II/III devices)
- Clinical evaluation – Demonstrate safety and efficacy through literature or trials
- Regulatory submission – File applications with the relevant authorities
Clinical testing requirements vary significantly. Many orthoses can rely on literature reviews and predicate device comparisons, while novel exoskeletons may require clinical trials. Documentation must demonstrate safety, efficacy, and quality throughout the device lifecycle.
What is the difference between Class I and Class II medical device certifications?
Class I devices pose minimal risk and typically require only registration and basic quality controls. Class II devices present moderate risk and need more comprehensive testing, clinical data, and often notified body review. The classification determines regulatory obligations, approval timelines, and ongoing compliance requirements.
Class I medical devices:
- Self-declaration of conformity may be possible
- Basic quality management requirements
- Simplified technical documentation
- Registration-based market entry
- Examples: simple ankle braces, basic walking aids
Class II medical devices:
- Notified body assessment required
- Comprehensive clinical evaluation needed
- Full quality management system audit
- Detailed technical documentation required
- Examples: powered exoskeletons, complex orthotic systems
Most balancing devices fall into Class I or Class II categories based on their invasiveness, duration of contact, and potential risks. Passive orthoses often qualify as Class I, while active exoskeletons with motors and control systems typically require Class II approval. For example, the Hermes ankle orthosis demonstrates how innovative orthotic devices can navigate complex regulatory pathways while maintaining clinical effectiveness.
Why do certification requirements vary between countries and regions?
Different regulatory bodies have varying standards because they developed independently to address local healthcare needs and safety concerns. The FDA focuses on premarket clearance, while CE marking emphasises conformity assessment. These differences reflect distinct regulatory philosophies, legal frameworks, and risk tolerance levels across jurisdictions.
Regional variations stem from several factors:
Regulatory philosophy differences:
- The FDA requires premarket review for most devices
- CE marking allows manufacturer self-declaration for lower-risk devices
- Health Canada combines elements of both approaches
Legal framework variations:
- Different liability and compensation systems
- Varying clinical evidence requirements
- Distinct quality system expectations
Harmonisation efforts through organisations such as the International Medical Device Regulators Forum (IMDRF) are reducing these differences. Mutual recognition agreements exist between some jurisdictions, allowing certain approvals to be recognised across borders. However, manufacturers still need region-specific strategies for global market access.
How InteSpring helps navigate medical device certification challenges
We guide clients through the complex certification landscape using our proven four-phase consultancy approach. Our regulatory expertise helps streamline the path from concept to certified product while ensuring compliance throughout development. We understand the specific requirements for balancing devices and exoskeletons across multiple markets.
Our certification support includes:
- Feasibility assessment – Early evaluation of regulatory pathways and requirements
- Classification guidance – Determining the appropriate device class and applicable standards
- Documentation development – Creating compliant technical files and quality systems
- Testing coordination – Managing safety, performance, and biocompatibility evaluations
- Regulatory strategy – Planning multi-market approval sequences for efficient global access
We work alongside your development team to embed regulatory considerations into the design process. This approach helps prevent costly redesigns and accelerates time to market. Our experience with balancing devices means we understand the unique challenges of demonstrating safety and efficacy for human–machine interface technologies. Learn more about our approach and expertise in bringing innovative medical devices to market.
Ready to navigate medical device certification for your balancing device? Contact us to discuss how our regulatory expertise can accelerate your path to market while ensuring full compliance across your target jurisdictions.